Advertisement
Canada markets open in 1 hour 28 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7299
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    81.29
    -0.61 (-0.74%)
     
  • Bitcoin CAD

    90,547.91
    +219.20 (+0.24%)
     
  • CMC Crypto 200

    1,417.57
    +2.81 (+0.20%)
     
  • GOLD FUTURES

    2,315.60
    -30.80 (-1.31%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,388.25
    +38.25 (+0.22%)
     
  • VOLATILITY

    16.63
    -0.31 (-1.83%)
     
  • FTSE

    8,047.61
    +23.74 (+0.30%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6833
    -0.0017 (-0.25%)
     

Amazon hits another all-time high, Alcoa soars on beat, Xerox and R.R. Donnelley jump on deal talk

Here are some of the stocks the Yahoo Finance team will be tracking for you today.

Amazon (AMZN) hit a fresh all-time high this morning. The e-commerce giant is hosting its second annual Prime Day event today. The 24-hour sale offers more than 100,000 deals to prime members.

Alcoa (AA) shares were sharply higher in early trading after it reported better-than-expected earnings and revenue for the second quarter. Even though weak aluminum prices continued to drag earnings and revenue lower from a year ago, Alcoa’s bottom line benefitted from cost cutting and productivity increases. The company also said its plans to split into two separate companies later this year remain on track.

Xerox (XRX) and R.R. Donnelley (RRD) are in focus following a Bloomberg report that the two companies are in talks to merge their copier businesses. This comes after Xerox announced earlier this year that it will split into two publicly traded companies—one selling and managing office equipment and the other providing office services.

ADVERTISEMENT

Shire’s (SHPG) U.S.-listed shares soared after the Food and Drug Administration approved its eye drops for treating dry eye disease. The solution is expected to go on sale in the third quarter and analysts estimate it could generate $1 billion a year in sales.

Tesla (TSLA) is under new scrutiny. The Securities and Exchange Commission is looking to see if Tesla broke any laws by not telling investors right away about a car accident that killed one person while the car was in autopilot mode, according to the Wall Street Journal.